HOME >> BIOLOGY >> NEWS
Protein sciences

Dr. Ruth Brack-Werner, Director of the GSF Institute of Molecular Virology (IMV) explains the decisive advantage of the new approach: " In previous assays, signals were generated only by interacting proteins, whereas the individual partners remained undetected. However, the absence of signals could not be used to rule out protein interactions since the absence of one or both interaction partners would have the same effect. To overcome this problem Brack-Werner and her team developed the so-called extended bimolecular fluorescence complementation (exBiFC) which allows simultaneous monitoring of individual proteins and their interactions.

Brack-Werner and her colleagues' groundbreaking research work focusses on mechanisms that control replication of the human immunodeficiency virus (HIV), which causes AIDS. "HIV replication is based on the interaction of cellular proteins with viral proteins. Interactions involving viral regulatory factors have a direct impact on the amount of virus produced by the HIV host cell", Brack-Werner explains. "Preventing HIV proteins from interacting with their crucial partners is a promising approach to developing novel therapies." Therefore the GSF-scientists developed and validated exBiFC with the HIV Rev protein, which is an accelerator of HIV production. Various assays investigating Rev interactions in artificial settings indicate that the activity of Rev depends on the interaction of Rev molecules with each other and with cellular proteins. The latter include Exportin 1, which transports proteins from the nucleus to the cytoplasm and RISP, a modulator of HIV gene expression discovered by the Brack-Werner team in previous studies. Brack-Werner and her team demonstrated that exBIFC allows visualization of interactions of Rev with itself and with Exportin1 and RISP in living cells. In addition they were able to compare the strengths of the interactions of Rev with its partners by analysing the intensities of the signals in
'"/>

Contact: Heinz Joerg Haury
oea@gsf.de
49-893-187-2460
GSF - National Research Center for Environment and Health
8-Mar-2007


Page: 1 2

Related biology news :

1. Protein chatter linked to cancer activation
2. Coming soon -- Protein synthesis without amino acids?
3. Protein pulling -- Learning how proteins fold by pulling them apart
4. Protein interactions targets for Huntington disease therapy
5. Protein enables discovery of quantum effect in photosynthesis
6. Protein found that slows hepatitis C growth in liver cells
7. Protein fragments sequenced in 68 million-year-old Tyrannosaurus rex
8. Protein averts cell suicide but might contribute to cancer
9. Protein structures for the entire yeast proteome
10. Protein overexpression at heart of heart failure
11. Protein identified that regulates effectiveness of Taxol chemotherapy in breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/7/2019)... ... November 07, 2019 , ... R3 Stem Cell is now offering ... rest of 2019. The code to use during checkout is FIFTYOFF and applies to ... the nation’s leader in regenerative therapies with over 12,000 successful stem cell procedures performed ...
(Date:11/6/2019)... , ... November 06, 2019 , ... ... version 2.0 today. The Genomic Search Engine now includes the ability to search ... further accelerate diagnosis of patients with genetic and rare diseases. , Patients, particularly ...
(Date:11/2/2019)... ... ... In this podcast, Smith spoke about the history of his career and ... Beyond the Lab Podcast is an interview series initiated by Vanderbilt University School of ... biomedical field — and in these interviews, the alumni discuss the different facets, challenges ...
Breaking Biology News(10 mins):
(Date:11/2/2019)... ... October 31, 2019 , ... drug360 graph, a ... tellic. drug360 brings tellic’s expertise in biomedical language processing and machine learning ... uncover relationships between genes, diseases, variants, phenotypes, and other biomedical entities. Researchers ...
(Date:10/29/2019)... ... , ... Modality Solutions, a biopharmaceutical cold chain ... workshop at the Biomanufacturing World Summit (BMWS19) Conference, November 11-12, 2019, at the ... World Summit brings together pharmaceutical executives, cutting-edge technology providers, and media partners ...
(Date:10/22/2019)... , ... October 22, 2019 , ... Catalent, a global ... Services and Drug Product Technologies Integration, will participate in a panel session titled “Cell ... to be held at the Gwen Hotel, Chicago, on Oct. 28-30, 2019. , The ...
(Date:10/17/2019)... ... October 16, 2019 , ... ... web-based genetic counseling information, has published a new white paper that explores how ... provides guidance as to how patients and medical providers can be kept informed ...
Breaking Biology Technology:
Cached News: